CDC advisers to decide on Omicron-retooled boosters on Sept 1

Advisers to the U.S. Centers for Disease Control and Prevention (CDC) will meet on Thursday to vote on whether to recommend the use of two COVID-19 vaccine boosters tailored against the Omicron variant. A recommendation in favor of the modified vaccines by Pfizer Inc and its German partner BioNTech SE, as well as Moderna Inc is expected to pave the way for a rollout next week.